{"id":"https://openalex.org/W2036658484","doi":"https://doi.org/10.1192/bjp.174.3.238","title":"Treatment of neuroleptic-induced akathisia with the 5-HT2antagonist mianserin: Double-blind, placebo-controlled study","display_name":"Treatment of neuroleptic-induced akathisia with the 5-HT2antagonist mianserin: Double-blind, placebo-controlled study","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2036658484","doi":"https://doi.org/10.1192/bjp.174.3.238","mag":"2036658484","pmid":"https://pubmed.ncbi.nlm.nih.gov/10448449"},"language":"en","primary_location":{"id":"doi:10.1192/bjp.174.3.238","doi":"https://doi.org/10.1192/bjp.174.3.238","is_oa":false,"landing_page_url":"https://doi.org/10.1192/bjp.174.3.238","pdf_url":null,"source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2036658484"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061817231","display_name":"Michael Poyurovsky","orcid":"https://orcid.org/0000-0003-3525-5743","observed_orcids":["https://orcid.org/0000-0003-3525-5743"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210152234","display_name":"Tirat Carmel Mental Health Center","ror":"https://ror.org/04jjkfw48","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210152234"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Poyurovsky","raw_affiliation_strings":["Research Unit, Tirat Carmel Mental Health Center, Israel","Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel and Faculty of Medicine, Israel Institute of Technology, Technion, Haifa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Unit, Tirat Carmel Mental Health Center, Israel","institution_ids":["https://openalex.org/I4210152234"]},{"raw_affiliation_string":"Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel and Faculty of Medicine, Israel Institute of Technology, Technion, Haifa","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210152234"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025199458","display_name":"Marina Shardorodsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210152234","display_name":"Tirat Carmel Mental Health Center","ror":"https://ror.org/04jjkfw48","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210152234"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marina Shardorodsky","raw_affiliation_strings":["Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel and Faculty of Medicine, Israel Institute of Technology, Technion, Haifa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel and Faculty of Medicine, Israel Institute of Technology, Technion, Haifa","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210152234"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102712589","display_name":"Camil Fuchs","orcid":"https://orcid.org/0000-0003-3130-5870","observed_orcids":["https://orcid.org/0000-0003-3130-5870"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Camil Fuchs","raw_affiliation_strings":["Department of Statistics and Operations Research, Tel Aviv University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Statistics and Operations Research, Tel Aviv University","institution_ids":["https://openalex.org/I16391192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017139630","display_name":"Michael Schneidman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210152234","display_name":"Tirat Carmel Mental Health Center","ror":"https://ror.org/04jjkfw48","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210152234"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Schneidman","raw_affiliation_strings":["Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel and Faculty of Medicine, Israel Institute of Technology, Technion, Haifa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Unit, Tirat Carmel Mental Health Center, Tirat Carmel and Faculty of Medicine, Israel Institute of Technology, Technion, Haifa","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210152234"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063898483","display_name":"Abraham Weizman","orcid":"https://orcid.org/0000-0002-9765-8938","observed_orcids":["https://orcid.org/0000-0002-9765-8938"]},"institutions":[{"id":"https://openalex.org/I4210143993","display_name":"Geha Mental Health Center","ror":"https://ror.org/03tp0ty93","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210143993","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Abraham Weizman","raw_affiliation_strings":["Laboratory of Biological Psychiatry, Geha Psychiatric Hospital, Petah Tiqva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Biological Psychiatry, Geha Psychiatric Hospital, Petah Tiqva, Israel","institution_ids":["https://openalex.org/I4210143993"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5063898483"],"corresponding_institution_ids":["https://openalex.org/I4210143993"],"apc_list":{"value":4920,"currency":"USD","value_usd":4920},"apc_paid":null,"fwci":3.1427,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.91137887,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"174","issue":"3","first_page":"238","last_page":"242"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroleptic-induced-akathisia","display_name":"neuroleptic-induced akathisia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/5-ht2-receptor-antagonist","display_name":"5-HT2 receptor antagonist","score":0.8730000257492065},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8410000205039978},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8080000281333923},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.920715868473053},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.9099639654159546},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6726219654083252},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6158827543258667},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5806228518486023},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.49375995993614197},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46779781579971313},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4160751700401306},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4060659408569336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38871750235557556},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3051411509513855},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.25652575492858887},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.15731516480445862},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017109","descriptor_name":"Akathisia, Drug-Induced","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017109","descriptor_name":"Akathisia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1192/bjp.174.3.238","doi":"https://doi.org/10.1192/bjp.174.3.238","is_oa":false,"landing_page_url":"https://doi.org/10.1192/bjp.174.3.238","pdf_url":null,"source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:10448449","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10448449","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of psychiatry : the journal of mental science","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1829839034","https://openalex.org/W1984445767","https://openalex.org/W1999689270","https://openalex.org/W2005622834","https://openalex.org/W2007251976","https://openalex.org/W2011832466","https://openalex.org/W2020844317","https://openalex.org/W2047320719","https://openalex.org/W2055587788","https://openalex.org/W2064872930","https://openalex.org/W2072069319","https://openalex.org/W2114613490","https://openalex.org/W2126198504","https://openalex.org/W2165379748","https://openalex.org/W2243407269","https://openalex.org/W2264118642","https://openalex.org/W2318882855","https://openalex.org/W2335460956","https://openalex.org/W2401206973","https://openalex.org/W2460399442","https://openalex.org/W3090293687","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2055587788","https://openalex.org/W2073098030","https://openalex.org/W2014503836","https://openalex.org/W2003451122","https://openalex.org/W2460399442","https://openalex.org/W1999626417","https://openalex.org/W2064872930","https://openalex.org/W2137172145","https://openalex.org/W2090471606","https://openalex.org/W2038570948"],"abstract_inverted_index":{"BACKGROUND:":[0],"Serotonin":[1],"(5-HT):dopamine":[2],"imbalance":[3],"may":[4,155],"underlie":[5],"neuroleptic-induced":[6,19,165],"akathisia.":[7,20,166],"AIM:":[8],"To":[9],"evaluate":[10],"the":[11,14,57,74,77,96,119,130,139],"efficacy":[12],"of":[13,100,113],"5-HT2":[15],"antagonist,":[16],"mianserin":[17,37,131],"in":[18,30,84,95,125,129,138],"METHODS:":[21],"Thirty":[22],"neuroleptic-treated":[23],"patients":[24,79,127,162],"with":[25,73,92,163],"schizophrenia":[26],"were":[27,46],"randomly":[28],"allocated":[29],"a":[31,81,152,157],"double-blind":[32],"design":[33],"to":[34,109],"receive":[35],"either":[36],"(15":[38],"mg/day)":[39],"or":[40],"placebo":[41,75,140],"for":[42,161],"five":[43],"days.":[44],"Patients":[45],"assessed":[47],"at":[48,114,151],"baseline":[49],"and":[50,54,102,133],"on":[51,118],"Days":[52],"3":[53],"5":[55],"by":[56,65,89],"Barnes":[58],"Akathisia":[59],"Scale":[60],"(BARS),":[61],"as":[62,64],"well":[63],"other":[66],"relevant":[67],"clinical":[68],"rating":[69],"scales.":[70],"RESULTS:":[71],"Compared":[72],"group,":[76],"mianserin-treated":[78],"showed":[80],"significant":[82],"reduction":[83,112],"all":[85],"four":[86],"BARS":[87,97,120],"subscales":[88],"Day":[90],"5,":[91],"mean":[93],"reductions":[94],"global":[98,121],"score":[99],"9.9%":[101],"52.2%,":[103],"respectively":[104],"(P":[105,142],"=":[106,143],"0.006).":[107],"Response":[108],"treatment":[110],"(a":[111],"least":[115],"two":[116],"points":[117],"subscale),":[122],"was":[123],"noted":[124],"six":[126],"(40%)":[128],"group":[132,141],"only":[134],"one":[135],"patient":[136],"(9.1%)":[137],"0.04,":[144],"log":[145],"odds":[146],"ratio":[147],"2.23).":[148],"CONCLUSIONS:":[149],"Mianserin":[150],"low":[153],"dose":[154],"be":[156],"promising":[158],"therapeutic":[159],"option":[160],"acute":[164]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2036658484","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
